Page last updated: 2024-09-03

imatinib mesylate and Atypical Ductal Hyperplasia

imatinib mesylate has been researched along with Atypical Ductal Hyperplasia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bi, L; Duan, J; Fan, Z; Pan, L; Qiao, W; Wu, D; Yang, M	1
England, RW; Scranton, SE; Wild, CA	1

Other Studies

2 other study(ies) available for imatinib mesylate and Atypical Ductal Hyperplasia

Article	Year
Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy. Breast cancer (Tokyo, Japan), 2017, Volume: 24, Issue:6 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mammography; Middle Aged; Neoplasms, Second Primary; Protein Kinase Inhibitors; Sentinel Lymph Node Biopsy; Ultrasonography, Doppler, Color	2017
Episodic angioedema with eosinophilia: successful treatment with imatinib. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2008, Volume: 100, Issue:2 Topics: Angioedema; Antineoplastic Agents; Benzamides; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diagnosis, Differential; Eosinophilia; Female; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Pyrimidines; Recurrence	2008

Article

Year

Secondary breast carcinoma after completely remitted chronic myeloid leukemia following targeted tyrosine kinase inhibitor therapy.

Breast cancer (Tokyo, Japan), 2017, Volume: 24, Issue:6

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Female; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mammography; Middle Aged; Neoplasms, Second Primary; Protein Kinase Inhibitors; Sentinel Lymph Node Biopsy; Ultrasonography, Doppler, Color

2017

Episodic angioedema with eosinophilia: successful treatment with imatinib.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2008, Volume: 100, Issue:2

Topics: Angioedema; Antineoplastic Agents; Benzamides; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Diagnosis, Differential; Eosinophilia; Female; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Pyrimidines; Recurrence

2008